Tumor Resection
Showing 9951 - 9975 of >10,000
Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer Trial in Detroit (docetaxel,
Completed
- Adenocarcinoma of the Prostate
- +3 more
- docetaxel
- +2 more
-
Detroit, MichiganBarbara Ann Karmanos Cancer Institute
Mar 2, 2021
Advanced or Metastatic Solid Tumor Trial in Beijing (Recombinant Humanized Monoclonal Antibody MIL97 for Injection)
Recruiting
- Advanced or Metastatic Solid Tumor
- Recombinant Humanized Monoclonal Antibody MIL97 for Injection
-
Beijing, Beijing, ChinaChinese PLA General Hospital
May 26, 2022
Post-operative Pain, Colon Cancer, Diverticulitis Trial in Des Moines (Bupivacaine, Bupivacaine liposome suspension)
Completed
- Post-operative Pain
- +2 more
- Bupivacaine
- Bupivacaine liposome suspension
-
Des Moines, IowaMercy Medical Center
Dec 14, 2020
Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Portland (Decitabine and
Not yet recruiting
- Acute Myeloid Leukemia
- +2 more
- Decitabine and Cedazuridine
- +2 more
-
Portland, OregonOHSU Knight Cancer Institute
May 25, 2022
Decipher® Testing - VANDAAM Study
Recruiting
- Prostate Cancer
- Decipher® Testing
-
Bay Pines, Florida
- +2 more
May 27, 2022
Breast Cancer, Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer Trial in Fairfax (Drug determined by
Recruiting
- Breast Cancer
- +2 more
- Drug determined by treating oncologist based on recommendation from systems biology analysis.
-
Fairfax, VirginiaInova Schar Cancer Institute
Oct 13, 2021
Childhood Atypical Teratoid/Rhabdoid Tumor Trial in Australia, Canada, United States (radiation, procedure, drug, biological,
Active, not recruiting
- Childhood Atypical Teratoid/Rhabdoid Tumor
- 3-Dimensional Conformal Radiation Therapy
- +11 more
-
Birmingham, Alabama
- +93 more
Feb 25, 2022
Sarcoma Trial in Seattle (drug, other, biological)
Completed
- Sarcoma
- Doxorubicin Hydrochloride
- +2 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
May 3, 2021
Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial in Houston (drug, procedure, device)
Active, not recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- Malignant Solid Neoplasm
- Methylprednisolone
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Feb 3, 2022
Functional Popliteal Artery Entrapment Syndrome, Popliteal Artery Entrapment Syndrome Trial in Redwood City (Dysport)
Withdrawn
- Functional Popliteal Artery Entrapment Syndrome
- Popliteal Artery Entrapment Syndrome
-
Redwood City, CaliforniaStanford University
Mar 4, 2021
Soft Tissue Sarcoma, Bone Sarcoma Trial in Houston (Cyclophosphamide, attIL2-T cells)
Not yet recruiting
- Soft Tissue Sarcoma
- Bone Sarcoma
- Cyclophosphamide
- attIL2-T cells
-
Houston, TexasM D Anderson Cancer Center
Nov 10, 2022
Colon Adenocarcinoma, Rectal Adenocarcinoma, Stage III Colorectal Cancer AJCC v7 Trial in United States (Clobetasol Propionate,
Active, not recruiting
- Colon Adenocarcinoma
- +8 more
- Clobetasol Propionate
- +3 more
-
Phoenix, Arizona
- +21 more
Jan 5, 2022
Hematological Tumors, Recurrence Trial in Shanghai (Peg interferon alfa-2b)
Recruiting
- Hematological Neoplasms
- Recurrence
- Peg interferon alfa-2b
-
Shanghai, Shanghai, ChinaShanghai Jiao Tong University Affilated First People's Hospital
Oct 10, 2021
Integrated Genomic Prostate Score With MRI Targeted Prostate
Active, not recruiting
- Prostate Cancer
-
Birmingham, Alabama
- +1 more
Jan 12, 2023
Rectal Cancer, Pathological Complete Response, Disease Free Survival Trial in Beijing (concurrent capecitabine-based long-term
Unknown status
- Rectal Cancer
- +2 more
- concurrent capecitabine-based long-term radiotherapy followed by 4 cycles XELOX and a delayed TME
- concurrent capecitabine-based long-term radiotherapy followed by a Regular TME and 6 Cycles XELOX
-
Beijing, Beijing, China
- +1 more
May 17, 2020
Glioblastoma, WHO Grade II Glioma, WHO Grade III Glioma Trial in Philadelphia (Intensity-Modulated Radiation Therapy,
Recruiting
- Glioblastoma
- +2 more
- Intensity-Modulated Radiation Therapy
- Quality-of-Life
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
Jun 3, 2021
Lung Cancer Trial in France (biological, drug, procedure)
Completed
- Lung Cancer
- filgrastim
- +4 more
-
Besancon, France
- +21 more
Feb 19, 2021
Benign Airway Stenosis, Respiratory Tract Fistula Trial in Guangzhou (Control group, SVF group)
Recruiting
- Benign Airway Stenosis
- Respiratory Tract Fistula
- Control group
- SVF group
-
Guangzhou, Guangdong, ChinaGuangzhou Institute of Respiratory Disease, The First Affiliated
Mar 19, 2022
Predictive Factors of Onset of Bone Metastases in Cancer
Completed
- Bone Metastases
-
Bagheria, Palermo, ItalyDipartimento Rizzoli Sicialia - Istituto Ortopedico Rizzoli
Mar 21, 2022
Malignant Melanoma, Lung Cancer, or Colorectal Cancer Trial in Suzhou (TAA06 injection)
Recruiting
- Malignant Melanoma, Lung Cancer, or Colorectal Cancer
- TAA06 injection
-
Suzhou, Jiangsu, ChinaPersonGen BioTherapeutics(Suzhou) Co., Ltd.
Dec 29, 2021
Breast Cancer Trial in Dallas (LA TNBC: DC vaccine+Preop chemo, ER+/HER2-BC:DC vaccine+Preop chemo)
Completed
- Breast Cancer
- LA TNBC: DC vaccine+Preop chemo
- ER+/HER2-BC:DC vaccine+Preop chemo
-
Dallas, TexasBaylor University Medical Center
Oct 7, 2021
Oral Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma Trial in Shanghai (Carrimycin)
Active, not recruiting
- Oral Squamous Cell Carcinoma
- Head and Neck Squamous Cell Carcinoma
-
Shanghai, Shanghai, ChinaNinth People's Hospital, School of Medicine, Shanghai Jiao Tong
May 13, 2021